U.S. markets closed
  • S&P 500

    4,080.11
    +122.48 (+3.09%)
     
  • Dow 30

    34,589.77
    +737.24 (+2.18%)
     
  • Nasdaq

    11,468.00
    +484.22 (+4.41%)
     
  • Russell 2000

    1,886.58
    +50.03 (+2.72%)
     
  • Crude Oil

    80.44
    +2.24 (+2.86%)
     
  • Gold

    1,782.70
    +19.00 (+1.08%)
     
  • Silver

    22.40
    +0.96 (+4.50%)
     
  • EUR/USD

    1.0410
    +0.0075 (+0.73%)
     
  • 10-Yr Bond

    3.7030
    -0.0450 (-1.20%)
     
  • GBP/USD

    1.2063
    +0.0113 (+0.95%)
     
  • USD/JPY

    138.0400
    -0.5940 (-0.43%)
     
  • BTC-USD

    17,094.39
    +625.52 (+3.80%)
     
  • CMC Crypto 200

    406.06
    +5.37 (+1.34%)
     
  • FTSE 100

    7,573.05
    +61.05 (+0.81%)
     
  • Nikkei 225

    27,968.99
    -58.85 (-0.21%)
     

Is the Options Market Predicting a Spike in Fulcrum (FULC) Stock?

Investors in Fulcrum Therapeutics, Inc. FULC need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 17, 2022 $22.50 Call had some of the highest implied volatility of all equity options today.

What is Implied Volatility?

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?

Clearly, options traders are pricing in a big move for Fulcrum shares, but what is the fundamental picture for the company? Currently, Fulcrum is a Zacks Rank #3 (Hold) in the Medical – Biomedical and Genetics industry that ranks in Bottom 33% of our Zacks Industry Rank. Over the last 60 days, one analyst has increased the earnings estimates for the current quarter, while three have revised their estimates downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from a loss of 62 cents per share to a loss of 61 cents in that period.

Given the way analysts feel about Fulcrum right now, this huge implied volatility could mean there’s a trade developing. Often times, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.

Looking to Trade Options?        

Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.

Click to see the trades now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Fulcrum Therapeutics, Inc. (FULC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research